20105 results for «»
20105 results
Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study
14 Aug 2022
The STRENGTH study is a multicentre prospective randomised trial investigating whether RenalGuard is superior to standard intravenous hydration in preventing contrast induced nephropathy in patients with chronic kidney disease (CKD) undergoing complex cardiovascular procedures.
Reviewer
Mahesh Ahire
Nashik, India
Khalil Ahmed
Karachi, Pakistan
Naveen Ahmed
Karnataka, India
Mohamed Alam
Agouza, Egypt
Abdulaziz Algethami
Riyadh, Saudi Arabia
Hamed Alghamdi
Dammam, Saudi Arabia
Mousa Aljohani
Riyadh, Saudi Arabia
Raed Alkutshan
Jubail industrial city, Saudi Arabia
Masataka Arakawa
Tokyo, Japan
An Shing Ang
Singapore, Singapore
Wongwaris Aphijirawat
Chon Buri, Thailand
Priyadarshini Arambam
New Delhi, India
Parneesh Arora
Delhi, India
PFO closure in 2019 – Who, Why and How?
20 Jul 2022
View this replay of a LIVE Round Table Webinar - PFO closure in 2019 – Who, Why and How?, with P. Calvert, C. Grasso and P. Lurz
Rakesh Aseri
Rajasthan, India
Baxtiyor Atamuratov
Tashkent, Uzbekistan
Siddharth Bajaj
Secunderabad, India
Nikola Bakracheski
Ohrid, North Macedonia
Andres Jr Baysa
Quezon, Philippines